Related Experiment Video
Updated: Oct 4, 2025

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
Published on: March 11, 2016
p-Cresyl Sulfate Predicts Ischemic Stroke among Patients on Hemodialysis: A Prospective Cohort Study
Xiao Tan1, Jianzhou Zou2, Fangfang Xiang2
1Department of Nephrology, Zhongshan Hospital, Fudan University, No. 180, Fenglin Road, Shanghai, China.
Insights
Elevated plasma p-cresyl sulfate levels are linked to a higher risk of ischemic stroke in patients undergoing hemodialysis. This finding highlights p-cresyl sulfate as a potential predictor for stroke events in this population.
Area of Science:
- Nephrology
- Cardiovascular Research
- Biomarker Discovery
Background:
- Hemodialysis patients face increased risks for cardiovascular events.
- Plasma p-cresyl sulfate is a uremic toxin with potential adverse health effects.
Purpose of the Study:
- To investigate the association between plasma p-cresyl sulfate levels and the incidence of ischemic stroke.
- To determine if p-cresyl sulfate can serve as a predictive biomarker for stroke in hemodialysis patients.
Main Methods:
- Prospective cohort study involving hemodialysis patients.
- Patients stratified into high and low plasma p-cresyl sulfate groups.
- Kaplan-Meier analysis and Cox proportional hazard models used for association analysis.
Main Results:
- Higher incidence of ischemic stroke observed in the high p-cresyl sulfate group (Log-Rank P = 0.007).
- Plasma p-cresyl sulfate significantly associated with ischemic stroke risk (HR 2.332, P = 0.009).
- Association remained significant after adjusting for confounding factors (HR 2.061, P = 0.041).
Conclusions:
- Plasma p-cresyl sulfate is a significant predictor of first ischemic stroke incidence.
- This finding supports the role of p-cresyl sulfate as a potential biomarker in hemodialysis patients.
Method:
Patients on hemodialysis over 6 months were enrolled in this prospective cohort study and were divided into 2 groups based on plasma p-cresyl sulfate level. The primary end point was the first episode of ischemic stroke during follow-up. The association between p-cresyl sulfate and ischemic stroke incidence was analyzed by Kaplan-Meier method and Cox proportional hazard model.
Results:
220 patients were enrolled in this study. 44 patients experienced episodes of first ischemic stroke during follow-up for 87.8 (47.6-119.5) months. Kaplan-Meier analysis demonstrated that the incidence of ischemic stroke in the high p-cresyl sulfate group was significantly higher than that in the low p-cresyl sulfate group (Log-Rank P = 0.007). Cox regression analysis as well proved that p-cresyl sulfate level was significantly associated with the first incidence of ischemic stroke (HR (hazard ratio) 2.332, 95% CI (95% confidence interval) 1.236-4.399, P = 0.009). After being adjusted for other confounding risk factors, the results persisted significant (model 11: HR 2.061, 95% CI 1.030-4.125, P = 0.041).
Conclusion:
Plasma p-cresyl sulfate predicts the first incidence of ischemic stroke in hemodialysis patients.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Hemodialysis II: Procedure and Complications
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Kidney Injury II: Pathophysiology
Hemodialysis I: Introduction

